Metronidazole 500 mg tablets are a widely recognized U.S. oral prescription presentation, but a product description containing “500 mg” needs careful reading. For tablets the number means 500 mg per immediate-release tablet; for LIKMEZ oral suspension, 500 mg/5 mL describes a liquid concentration. Neither is the same as a vaginal gel expressed as a percentage. A pharmacy should match the written order's route, dosage form and strength before dispensing.
The 500 mg tablet is also frequently mentioned in medical discussions of bacterial vaginosis and some other infections. A general shopping page should not turn those discussions into a self-selected treatment course. The clinician decides whether systemic oral treatment is appropriate for the diagnosed condition, and that decision may differ from the choice of a vaginal product. Compare prescription vaginal gel only to understand route differences, not to swap formulations.
This is a strength-specific product guide, not a duplicate of the 250 mg and 500 mg tablet hub. It focuses on what “500 mg oral tablet” means, how the former branded FLAGYL tablet relates to modern generics, and why pharmacy labels and prescription details take priority over search snippets. For the separate question of accessing a licensed pharmacy, see the U.S. purchasing guide.
Metronidazole 500 mg oral tablets contain 500 mg of the active ingredient in each immediate-release tablet. The product label should specify that the medicine is taken orally and belongs to the tablet form. The active drug name alone is not enough when search results also include capsules, oral suspensions, vaginal gels and skin treatments.
A useful product check includes strength, formulation, intended route, package and manufacturer or labeler. If the offered item says 500 mg/5 mL, it is a liquid concentration, not an oral tablet. If it says 0.75% gel, the concentration and route are entirely different. Do not infer identity from a shared number.
| Product description | Meaning of the number | Pharmacy question |
|---|---|---|
| 500 mg oral tablet | 500 mg in each immediate-release tablet | Is this the tablet ordered? |
| 250 mg oral tablet | 250 mg in each tablet | Has any strength change been authorized? |
| LIKMEZ 500 mg/5 mL | 500 mg in five milliliters of liquid | Was a suspension prescribed? |
| 750 mg ER tablet | 750 mg in modified-release tablet | Does the order specify ER? |
| 0.75% vaginal gel | Drug concentration in intravaginal gel | Is this a vaginal prescription instead? |
The U.S. market includes FDA-approved generic metronidazole tablet products in the 500 mg strength. Different labelers may supply distinct tablet imprints and package configurations while meeting applicable approval requirements. A dispensing label should identify the actual medicine and strength, and a pharmacist can check an unfamiliar appearance or manufacturer entry.
Generic status does not imply current pharmacy stock or the lowest price at every outlet. Neither an NDC number nor an FDA label proves a particular pharmacy will supply a specific package today. The generic product guide explains how therapeutic equivalence fits into that verification.
Branded FLAGYL 500 mg tablets are listed as discontinued in FDA's Orange Book. A 2024 FDA determination explained that the withdrawal from sale was not for reasons of safety or effectiveness. The regulatory status of that brand presentation should be differentiated from approved generic 500 mg tablets, which may be offered under their own labeling.
Do not rely on a webpage describing “buy Flagyl 500 mg” as evidence of branded supply. A pharmacist can identify the dispensed product and clarify whether a brand-specific prescription needs adjustment. For broader background on capsules and other branded formulations, see Flagyl product history.
Oral metronidazole 500 mg is mentioned in treatment guidelines for certain conditions, but the appropriate diagnosis, regimen and patient factors belong to a clinician's assessment. A patient with vaginal symptoms, for example, may require testing or examination before treatment is selected. The existence of both oral tablets and vaginal gels does not mean a shopper can choose between them based on convenience or a percentage of the drug.
Some infections require systemic therapy, some require a different agent, and some symptoms are not caused by bacteria susceptible to metronidazole at all. The CDC's bacterial vaginosis guidance provides clinical context, while prescribing and dispensing decisions remain individualized. The prescription process explains what the pharmacy needs after that clinical decision.
LIKMEZ's label expresses a liquid strength of 500 mg per 5 mL. The amount of medicine in a prescribed liquid volume must be measured accurately using a calibrated oral device. A tablet has a fixed amount per unit instead. Even when both are oral medicines containing metronidazole, differences in formulation, excipients, administration and packaging may matter.
If a patient cannot swallow tablets, the clinician and pharmacist should discuss an appropriate alternative rather than crushing or replacing the medicine without checking labeling. The oral suspension guide focuses on approved liquid products and compounded preparations.
Regular 500 mg oral tablets should not be confused with the 750 mg ER formulation. An ER product is engineered for a different release pattern and comes with product-specific rules, including swallowing the tablet whole. Switching from one to the other is not a simple ratio of milligrams and must not be improvised at the pharmacy counter.
If a prescription names ER, the pharmacy must verify that designation. Likewise, if the prescription specifies a standard 500 mg tablet, a seller's 750 mg ER page is not a direct substitute. The 750 mg ER page explains that distinction without turning it into dosing advice.
Read the ordered strength, oral tablet form, directions and quantity before comparing pharmacy offers. The dispensing container should agree with the prescription, including whether the product is a generic and which formulation is supplied. Clarify any difference in brand preference or manufacturer identity if relevant to the prescription.
If the tablet imprint differs from what you recognize, a pharmacist can check it against records; visual memory is not sufficient. When the pharmacy proposes a different tablet strength or formulation, ask whether the change is clinically and legally authorized. Verify current inventory directly rather than relying on a static label listing.
A shortened listing may say only “metronidazole 500,” leaving uncertain whether it refers to a conventional tablet, a particular branded reference, an oral liquid concentration or a historical product identifier. A legitimate pharmacy can clarify the route, dosage form, strength, package and dispensing label. If the record is ambiguous, it should not be used to choose a medicine without checking the underlying prescription.
For a 500 mg tablet order, the formulation and quantity are important even where two generic manufacturers list the same active ingredient. Patients should ask whether the pharmacy has the prescribed immediate-release tablet rather than an ER tablet, capsule or liquid. Product identity is more stable than a retail search title, while live stock and prices are not.
Many readers arrive at a 500 mg tablet page after reading an infection treatment guideline. Guidelines are written for clinical decision-making, not as permission to obtain a drug without diagnosis. Bacterial vaginosis is one example where oral tablets and vaginal gels both appear in professional discussions but have different routes and instructions. A patient should not interpret the existence of multiple labeled options as automatic therapeutic equivalence for their own condition.
Before pursuing a pharmacy fill, confirm that the clinician selected the oral route and issued the appropriate prescription. If symptoms suggest another disorder or require additional testing, medicine selection may need to be reconsidered. Keeping the page centered on 500 mg tablet identity prevents it from duplicating the BV treatment guide while still helping the reader match a legitimate product.
A commonly discussed tablet strength does not imply that metronidazole is appropriate for any infection. Oral metronidazole has significant warnings and interaction concerns that should be reviewed against the patient's medication list and health history. A clinician may need information about allergies, neurological symptoms, liver disease or other therapies before prescribing.
Do not use extra tablets to extend a course, save the remainder for a new illness or attempt to adapt a guideline's example dose without medical supervision. The correct product and instructions should remain tied to the specific prescribed treatment. Ask the pharmacist for clarification when labeling and verbal advice appear inconsistent.
It is a strength of oral immediate-release metronidazole tablets in the United States. Each tablet contains 500 mg of the active ingredient.
No. Oral metronidazole tablets require a valid U.S. prescription and must be dispensed by an appropriately licensed pharmacy.
Oral metronidazole may be prescribed for BV under clinical guidelines, but the diagnosis and regimen must be determined by a qualified clinician. It is not a self-treatment decision.
No. They have different routes, formulations and labeled uses. The percentage concentration on a gel cannot be converted into a tablet prescription.
No. LIKMEZ is an oral suspension, and 500 mg/5 mL expresses a liquid concentration. A prescribed volume is measured using a calibrated oral device.
The branded FLAGYL 500 mg tablet appears on the FDA discontinued product list. This does not mean approved generic 500 mg tablets have all been discontinued.
Do not make tablet-strength substitutions on your own. A pharmacist or prescriber must decide whether any change is appropriate under the prescription.
No. The latter is an extended-release tablet with a different release design and instructions; it is not an interchangeable higher-strength version.
Ask the pharmacist to verify the drug name, strength, manufacturer and imprint. Differences in appearance may reflect different approved generic products, but should be confirmed.
Compare the exact oral form, 500 mg strength, prescribed quantity and dispensing terms. Confirm a valid prescription, pharmacy legitimacy and actual availability directly.